{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:40:50Z","timestamp":1792816850056,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98926-9","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T09:21:43Z","timestamp":1746696103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Zahra","family":"Zia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Javad","family":"Sajadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Bazrafshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Khademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Janipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"98926_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-016-0189-1","volume":"16","author":"N Jiang","year":"2016","unstructured":"Jiang, N. et al. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. BMC Ophthalmol. 16, 1\u20137 (2016).","journal-title":"BMC Ophthalmol."},{"key":"98926_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.46912\/jbrcp.139","volume":"3","author":"C Ojabo","year":"2020","unstructured":"Ojabo, C., Adekwu, A. & Ben-Ameh, T. Multi-disciplinary approach in management of Rhino-orbito-cerebral mucormycosis in Resource-poor setting in Sub-saharan Africa: A case report. J. BioMedical Res. Clin. Pract. 3, 272\u2013276 (2020).","journal-title":"J. BioMedical Res. Clin. Pract."},{"key":"98926_CR3","first-page":"75","volume":"15","author":"K Shamanna","year":"2019","unstructured":"Shamanna, K., Fathima, A. & Sowjanya, S. Rhino-Orbito-Cerebral mucormycosis: our experience. Headache 15, 75 (2019).","journal-title":"Headache"},{"key":"98926_CR4","unstructured":"Sipsas, N., Gamaletsou, M., Anastasopoulou, A. & Kontoyiannis D. (2018)."},{"key":"98926_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.22207\/JPAM.13.1.16","volume":"13","author":"R Suganya","year":"2019","unstructured":"Suganya, R., Malathi, N., Karthikeyan, V. & Janagaraj, V. D. Mucormycosis: a brief review. J. Pure Appl. Microbiol. 13, 161\u2013165 (2019).","journal-title":"J. Pure Appl. Microbiol."},{"key":"98926_CR6","first-page":"227","volume":"11","author":"M Salehi","year":"2020","unstructured":"Salehi, M. et al. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report. Caspian J. Intern. Med. 11, 227 (2020).","journal-title":"Caspian J. Intern. Med."},{"key":"98926_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12371","volume":"20","author":"O Cornely","year":"2014","unstructured":"Cornely, O. et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin. Microbiol. Infect. 20, 5\u201326 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"98926_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ajo.2021.05.025","volume":"237","author":"DC Ashraf","year":"2022","unstructured":"Ashraf, D. C. et al. Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin B for invasive fungal rhino-orbital sinusitis. Am. J. Ophthalmol. 237, 299\u2013309 (2022).","journal-title":"Am. J. Ophthalmol."},{"key":"98926_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","volume":"69","author":"SG Honavar","year":"2021","unstructured":"Honavar, S. G., Code & Mucor Guidelines for the diagnosis, staging and management of Rhino-Orbito-Cerebral mucormycosis in the setting of COVID-19. Indian J. Ophthalmol. 69, 1361\u20131365. https:\/\/doi.org\/10.4103\/ijo.IJO_1165_21 (2021).","journal-title":"Indian J. Ophthalmol."},{"key":"98926_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/icu.0000000000000394","volume":"28","author":"E Kalin-Hajdu","year":"2017","unstructured":"Kalin-Hajdu, E., Hirabayashi, K. E., Vagefi, M. R. & Kersten, R. C. Invasive fungal sinusitis: treatment of the orbit. Curr. Opin. Ophthalmol. 28, 522\u2013533. https:\/\/doi.org\/10.1097\/icu.0000000000000394 (2017).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"98926_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon, C. Lifelines: survival analysis in Python. J. Open. Source Softw. 4, 1317 (2019).","journal-title":"J. Open. Source Softw."},{"key":"98926_CR12","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/jfmpc.jfmpc_636_23","volume":"12","author":"V Sharma","year":"2023","unstructured":"Sharma, V. & Tuli, I. P. Rhino-Orbito-Cerebral mucormycosis (ROCM) in COVID-19 patients. J. Family Med. Prim. Care. 12, 1472\u20131473. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_636_23 (2023).","journal-title":"J. Family Med. Prim. Care"},{"key":"98926_CR13","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.4103\/ijo.Ijo_356_23","volume":"71","author":"V Verma","year":"2023","unstructured":"Verma, V. et al. Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care Institute of central India. Indian J. Ophthalmol. 71, 3669\u20133676. https:\/\/doi.org\/10.4103\/ijo.Ijo_356_23 (2023).","journal-title":"Indian J. Ophthalmol."},{"key":"98926_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1186\/s12879-024-09755-6","volume":"24","author":"B Eshraghi","year":"2024","unstructured":"Eshraghi, B. et al. Risk factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study. BMC Infect. Dis. 24, 852 (2024).","journal-title":"BMC Infect. Dis."},{"key":"98926_CR15","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","volume":"13","author":"MA Chowdhury","year":"2020","unstructured":"Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A. & Alam, A. Immune response in COVID-19: A review. J. Infect. Public Health. 13, 1619\u20131629 (2020).","journal-title":"J. Infect. Public Health"},{"key":"98926_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41418-022-01015-x","volume":"29","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Immune response in COVID-19: what is next? Cell. Death Differ. 29, 1107\u20131122 (2022).","journal-title":"Cell. Death Differ."},{"key":"98926_CR17","doi-asserted-by":"publisher","unstructured":"Almyroudi, M. P., Akinosoglou, K., Rello, J., Blot, S. & Dimopoulos, G. Clinical phenotypes of COVID-19 associated mucormycosis (CAM): A comprehensive review. Diagnostics (Basel). 12 https:\/\/doi.org\/10.3390\/diagnostics12123092 (2022).","DOI":"10.3390\/diagnostics12123092"},{"key":"98926_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/sja.sja_640_22","volume":"17","author":"A Gupta","year":"2023","unstructured":"Gupta, A., Kayarat, B. & Gupta, N. COVID-19 associated mucormycosis (CAM): implications for perioperative physicians - A narrative review. Saudi J. Anaesth. 17, 58\u201364. https:\/\/doi.org\/10.4103\/sja.sja_640_22 (2023).","journal-title":"Saudi J. Anaesth."},{"key":"98926_CR19","doi-asserted-by":"publisher","unstructured":"Al-Ani, R. M. & Al Tameemi, K. M. COVID-19-related Rhino-orbital-cerebral Mucormycosis. Qatar Med J 47, (2022). https:\/\/doi.org\/10.5339\/qmj.2022.47 (2022).","DOI":"10.5339\/qmj.2022.47"},{"key":"98926_CR20","doi-asserted-by":"publisher","unstructured":"Hassan, R. M. et al. Magnetic resonance imaging features of Rhino-Orbito-Cerebral mucormycosis in Post-COVID-19 patients: Radio-Pathological correlation. Diagnostics (Basel). 13. https:\/\/doi.org\/10.3390\/diagnostics13091546 (2023).","DOI":"10.3390\/diagnostics13091546"},{"key":"98926_CR21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.acra.2022.12.011","volume":"30","author":"B Khademi","year":"2023","unstructured":"Khademi, B., Dehghan, A., Zia, Z. & Dehghan, Y. Imaging spectrum of coronavirus Disease- 2019 associated Rhino-Orbital-Cerebral mucormycosis; from sinonasal inflammation to intracranial involvement. Acad. Radiol. 30, 1904\u20131914. https:\/\/doi.org\/10.1016\/j.acra.2022.12.011 (2023).","journal-title":"Acad. Radiol."},{"key":"98926_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF02907665","volume":"57","author":"N Kulkarni","year":"2005","unstructured":"Kulkarni, N., Bhide, A. & Wadia, R. Rhinocerebral mucormycosis: an analysis of probable mode of spread and its implication in an early diagnosis and treatment. Indian J. Otolaryngol. Head Neck Surg. 57, 121\u2013124 (2005).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"98926_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12070-013-0659-1","volume":"65","author":"K Sachdeva","year":"2013","unstructured":"Sachdeva, K. Rhino-oculo cerebral mucormycosis with multiple cranial nerve palsy in diabetic patient: review of six cases. Indian J. Otolaryngol. Head Neck Surg. 65, 375\u2013379 (2013).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"98926_CR24","doi-asserted-by":"publisher","first-page":"100771","DOI":"10.1016\/j.ajoc.2020.100771","volume":"19","author":"M Safi","year":"2020","unstructured":"Safi, M., Ang, M. J., Patel, P. & Silkiss, R. Z. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B. Am. J. Ophthalmol. Case Rep. 19, 100771 (2020).","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"98926_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/myc.12474","volume":"59","author":"A Vaezi","year":"2016","unstructured":"Vaezi, A., Moazeni, M., Rahimi, M. T., de Hoog, S. & Badali, H. Mucormycosis in Iran: a systematic review. Mycoses 59, 402\u2013415 (2016).","journal-title":"Mycoses"},{"key":"98926_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","volume":"39","author":"JJ Vehreschild","year":"2013","unstructured":"Vehreschild, J. J. et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit. Rev. Microbiol. 39, 310\u2013324. https:\/\/doi.org\/10.3109\/1040841X.2012.711741 (2013).","journal-title":"Crit. Rev. Microbiol."},{"key":"98926_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cmi.2016.03.029","volume":"22","author":"A Kyvernitakis","year":"2016","unstructured":"Kyvernitakis, A. et al. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin. Microbiol. Infect. 22, 811 (2016). e811-811. e818.","journal-title":"Clin. Microbiol. Infect."},{"key":"98926_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/myc.12236","volume":"57","author":"E Roilides","year":"2014","unstructured":"Roilides, E., Antachopoulos, C. & Simitsopoulou, M. Pathogenesis and host defence against mucorales: the role of cytokines and interaction with antifungal drugs. Mycoses 57, 40\u201347 (2014).","journal-title":"Mycoses"},{"key":"98926_CR29","doi-asserted-by":"publisher","first-page":"7891","DOI":"10.4103\/jfmpc.jfmpc_1433_22","volume":"11","author":"N Singh","year":"2022","unstructured":"Singh, N. et al. Trends of rhino-orbito-cerebral mucormycosis in COVID-19 patients: an observational study. J. Family Med. Prim. Care. 11, 7891\u20137896. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1433_22 (2022).","journal-title":"J. Family Med. Prim. Care"},{"key":"98926_CR30","first-page":"987","volume":"14","author":"A Mallis","year":"2010","unstructured":"Mallis, A., Mastronikolis, S., Naxakis, S. & Papadas, A. Rhinocerebral mucormycosis: an update. Eur. Rev. Med. Pharmacol. Sci. 14, 987\u2013992 (2010).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"98926_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(16)00127-4","volume":"16","author":"E Roilides","year":"2016","unstructured":"Roilides, E. & Antachopoulos, C. Isavuconazole: an Azole active against mucormycosis. Lancet Infect. Dis. 16, 761\u2013762 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"98926_CR32","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1093\/cid\/cir869","volume":"54","author":"E Roilides","year":"2012","unstructured":"Roilides, E., Kontoyiannis, D. P. & Walsh, T. J. Host defenses against zygomycetes. Clin. Infect. Dis. 54, S61\u2013S66 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"98926_CR33","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s10792-022-02556-3","volume":"43","author":"A Gandhi","year":"2023","unstructured":"Gandhi, A. et al. Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study. Int. Ophthalmol. 43, 1571\u20131580. https:\/\/doi.org\/10.1007\/s10792-022-02556-3 (2023).","journal-title":"Int. Ophthalmol."},{"key":"98926_CR34","doi-asserted-by":"publisher","unstructured":"Lynch, J. P. 3, Fishbein, M. C., Abtin, F., Zhanel, G. G. & rd, & Part 1: mucormycosis: prevalence, risk factors, clinical features, and diagnosis. Expert Rev. Anti Infect. Ther. 21, 723\u2013736. https:\/\/doi.org\/10.1080\/14787210.2023.2220964 (2023).","DOI":"10.1080\/14787210.2023.2220964"},{"key":"98926_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","volume":"16","author":"FM Marty","year":"2016","unstructured":"Marty, F. M. et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet. Infect. Dis. 16, 828\u2013837 (2016).","journal-title":"Lancet. Infect. Dis"},{"key":"98926_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s40506-015-0050-8","volume":"7","author":"MH Miceli","year":"2015","unstructured":"Miceli, M. H. & Kauffman, C. A. Treatment options for mucormycosis. Curr. Treat. Options Infect. Dis. 7, 142\u2013154. https:\/\/doi.org\/10.1007\/s40506-015-0050-8 (2015).","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"98926_CR37","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s10792-022-02591-0","volume":"43","author":"J Shakrawal","year":"2023","unstructured":"Shakrawal, J. et al. Outcomes of transcutaneous retrobulbar amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19. Int. Ophthalmol. 43, 1919\u20131926. https:\/\/doi.org\/10.1007\/s10792-022-02591-0 (2023).","journal-title":"Int. Ophthalmol."},{"key":"98926_CR38","doi-asserted-by":"publisher","first-page":"e45240","DOI":"10.7759\/cureus.45240","volume":"15","author":"R Cumpa-Quiroz","year":"2023","unstructured":"Cumpa-Quiroz, R., Elguera-Falc\u00f3n, F. & Guevara-Lazo, D. R. Emergence of Rhino-Orbito-Cerebral mucormycosis in Peru: impact of the COVID-19 pandemic. Cureus 15, e45240. https:\/\/doi.org\/10.7759\/cureus.45240 (2023).","journal-title":"Cureus"},{"key":"98926_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11046-021-00584-8","volume":"186","author":"V Muthu","year":"2021","unstructured":"Muthu, V., Rudramurthy, S. M., Chakrabarti, A. & Agarwal, R. Epidemiology and pathophysiology of COVID-19-Associated mucormycosis: India versus the rest of the world. Mycopathologia 186, 739\u2013754. https:\/\/doi.org\/10.1007\/s11046-021-00584-8 (2021).","journal-title":"Mycopathologia"},{"key":"98926_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/ijo.Ijo_2543_22","volume":"72","author":"A Raj","year":"2024","unstructured":"Raj, A. et al. Survival benefit of exenteration in COVID-19-associated rhino-orbital mucormycosis. Indian J. Ophthalmol. 72, 190\u2013194. https:\/\/doi.org\/10.4103\/ijo.Ijo_2543_22 (2024).","journal-title":"Indian J. Ophthalmol."},{"key":"98926_CR41","doi-asserted-by":"publisher","unstructured":"Juli\u00e1n Castrej\u00f3n, A. et al. The comprehensive management of patients with Rhino-Orbito-Cerebral mucormycosis; A perspective from antifungal treatment to prosthetic rehabilitation: A descriptive cohort study. Trop. Med. Infect. Dis. 9 https:\/\/doi.org\/10.3390\/tropicalmed9070158 (2024).","DOI":"10.3390\/tropicalmed9070158"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98926-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98926-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T09:21:45Z","timestamp":1746696105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98926-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98926"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98926-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Shiraz university of Medical Sciences Institutional Review Board (IRB) with the ethical approval number IR.SUMS.MED.REC. IR.1400.169. The study adhered to the tenets of the Declaration of Helsinki. All participants in this study completed an informed consent form for participation, publication of information, and use of images in the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16088"}}